MedPath

AKYNZEO

AKYNZEO

Approved
DIN Number

02468735

Drug Class

Human

Market Date

Nov 20, 2017

Company
HC

knight therapeutics inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02468735
AIG Number0259550001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A04AA55 PALONOSETRON, COMBINATIONS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:22.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

NETUPITANTActive
Strength: 300 MG
Monograph: NETUPITANT
PALONOSETRON (PALONOSETRON HYDROCHLORIDE)Active
Strength: 0.5 MG
Monograph: PALONOSETRON (PALONOSETRON HYDROCHLORIDE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.